UNITED THERAPEUTICS Corp (UTHR) Insider Trading

Sector: Biotechnology · Market Cap: $23.6B · 0 insider purchases in the last 7 days

No open market insider purchases at UNITED THERAPEUTICS Corp in the last 7 days.

Want more?

Sign up free to see 30+ days of history, set alerts, and track UTHR on your watchlist.

Start for Free

About UNITED THERAPEUTICS Corp Insider Trading

1 insider at UNITED THERAPEUTICS Corp (UTHR) has purchased stock in the past 90 days, totaling $864K across 1 transaction (1,500 shares).

The most recent purchase was by CEO ROTHBLATT MARTINE A on May 26, 2026 — a $864K buy of 1,500 shares at $575.96, bringing their total holdings to 43,153 shares.

UTHR is in the Biotechnology sector within the Biotechnology industry with a market cap of $23.6B.

Track UTHR insider trading activity, set up email alerts, and get AI-powered trade analysis with a free Insider Trading Tracker account.

Members of Congress Trading UTHR

Politicians who have disclosed trades in UNITED THERAPEUTICS Corp (UTHR) in the last 12 months.

POLITICIANPARTYTRADESLAST TRADE
Lisa McclainR3Oct 31, 2025
Michael T. McCaulR3Oct 27, 2025
View all congressional trading activity →

More Insider Trading in Biotechnology

Related Screeners